These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9825476)

  • 1. Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.
    Jensen RT; Gibril F; Termanini B
    Yale J Biol Med; 1997; 70(5-6):481-500. PubMed ID: 9825476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors.
    Gibril F; Jensen RT
    Yale J Biol Med; 1997; 70(5-6):509-22. PubMed ID: 9825478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor scintigraphy in gastrinomas.
    Jensen RT; Gibril F
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
    Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
    J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
    Termanini B; Gibril F; Doppman JL; Reynolds JC; Stewart CA; Sutliff VE; Venzon DJ; Jensen RT
    Radiology; 1997 Jan; 202(1):151-8. PubMed ID: 8988205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
    Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
    J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.
    Gibril F; Reynolds JC; Chen CC; Yu F; Goebel SU; Serrano J; Doppman JL; Jensen RT
    J Nucl Med; 1999 Apr; 40(4):539-53. PubMed ID: 10210211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
    Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
    Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management.
    Termanini B; Gibril F; Reynolds JC; Doppman JL; Chen CC; Stewart CA; Sutliff VE; Jensen RT
    Gastroenterology; 1997 Feb; 112(2):335-47. PubMed ID: 9024287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
    Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
    Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
    Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
    J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role.
    Cimitan M; Buonadonna A; Cannizzaro R; Canzonieri V; Borsatti E; Ruffo R; De Apollonia L
    Ann Oncol; 2003 Jul; 14(7):1135-41. PubMed ID: 12853358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
    Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pre- and intraoperative localization of neuroendocrine tumors].
    Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
    Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
    Jamar F; Fiasse R; Leners N; Pauwels S
    J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
    Kumbasar B; Kamel IR; Tekes A; Eng J; Fishman EK; Wahl RL
    Abdom Imaging; 2004; 29(6):696-702. PubMed ID: 15162235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of somatostatin receptor scintigraphy and CT/MRI on the clinical management of patients with gastrointestinal neuroendocrine tumors: an analysis in 188 patients.
    Gotthardt M; Dirkmorfeld LM; Wied MU; Rinke A; Béhé MP; Schlieck A; Höffken H; Alfke H; Joseph K; Klose KJ; Behr TM; Arnold R
    Digestion; 2003; 68(2-3):80-5. PubMed ID: 14581764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
    Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
    J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasonography of neuroendocrine tumours.
    Zimmer T; Scherübl H; Faiss S; Stölzel U; Riecken EO; Wiedenmann B
    Digestion; 2000; 62 Suppl 1():45-50. PubMed ID: 10940687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.